Literature DB >> 15060808

Essential requirements for practice guidelines at national and local levels.

F Nonino1, A Liberati.   

Abstract

We explored whether local practice guidelines (PGs) on stroke management had undergone a process of local adaptation in relation to the appropriate and feasible configuration of stroke units (SUs). We critically appraised 7 PGs developed by 6 Italian local healthcare units, using explicit criteria to evaluate internal validity and their adequacy relative to local implementation issues. All PGs were developed by multidisciplinary working groups. In 4 of 6 PGs recommending SUs for stroke care, methodology for evidence retrieval was poor. Although organisational aspects were addressed in 4 of 6 PGs, details on how a SU should be organised were not provided in any of the examined PGs. Despite availability of national and international stroke PGs, at local level guidelines developers seem to spend time in "reinventing the wheel" rather than concentrating on what matters for local implementation. Besides being inefficient, this seems to lead to methodologically poor products inappropriate for what should be done to assure that interventions that work are packaged in a way that is compatible with their uptake into the ongoing services activities.

Entities:  

Mesh:

Year:  2004        PMID: 15060808     DOI: 10.1007/s10072-004-0217-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  2 in total

1.  Challenges in developing national HIV guidelines: experience from the eastern Mediterranean.

Authors:  Anja De Weggheleire; Veronique Bortolotti; Maria Zolfo; Siobhan Crowley; Robert Colebunders; Gabriele Riedner; Lutgarde Lynen
Journal:  Bull World Health Organ       Date:  2011-04-29       Impact factor: 9.408

Review 2.  Appraisal tools for clinical practice guidelines: a systematic review.

Authors:  Ulrich Siering; Michaela Eikermann; Elke Hausner; Wiebke Hoffmann-Eßer; Edmund A Neugebauer
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.